Glutaminyl-peptide Cyclotransferase/QPCT Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-00185
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Glutaminyl-peptide Cyclotransferase/QPCT Antibody
Immunogen
Produced in rabbits immunized with purified, recombinant Human Glutaminyl-peptide Cyclotransferase/QPCT (Uniprot#: Q16769-1; Ala33-Leu361)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
This antibody can be stored at 2C to 8C for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20C to -80C. Avoid repeated freeze-thaw cycles.
Applications for Glutaminyl-peptide Cyclotransferase/QPCT Antibody
Application
Recommended Usage
ELISA
1:1000-1:2000
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
0.2 um filtered solution in PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Glutaminyl-peptide Cyclotransferase/QPCT
Alternate Names
GCT, Glutaminyl cyclase, Glutamyl cyclase
Gene Symbol
QPCT
Additional Glutaminyl-peptide Cyclotransferase/QPCT Products
Product Documents for Glutaminyl-peptide Cyclotransferase/QPCT Antibody
Product Specific Notices for Glutaminyl-peptide Cyclotransferase/QPCT Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...